Novartis: Investor Day (Novartis) - Nov 23, 2013 - Anticipated filing in US for familial chylomicronemia syndrome between Dec 2014 - Nov 2015; Anticipated filing in EU for familial chylomicronemia syndrome between Dec 2014 - Nov 2015; Anticipated approval in US for familial chylomicronemia syndrome between Dec 2014 - Nov 2015; Anticipated approval in EU for familial chylomicronemia syndrome between Dec 2014 - Nov 2015
Anticipated EU regulatory • Anticipated FDA event • Dyslipidemia
|